Profil
Heikki Joensuu is currently the Vice President-Therapy Area Oncology, R&D at Orion Oyj since 2017.
Prior to this, he worked as the Scientific Director at Boneca Oy.
Aktive Positionen von Heikki Joensuu
Unternehmen | Position | Beginn |
---|---|---|
ORION OYJ | Corporate Officer/Principal | 01.12.2017 |
Ehemalige bekannte Positionen von Heikki Joensuu
Unternehmen | Position | Ende |
---|---|---|
Boneca Oy
Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Chief Tech/Sci/R&D Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORION OYJ | Health Technology |
Private Unternehmen | 1 |
---|---|
Boneca Oy
Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Health Technology |